Stockholders' Deficit |
2 Months Ended | 9 Months Ended |
|---|---|---|
Dec. 31, 2019 |
Sep. 30, 2020 |
|
| Equity [Abstract] | ||
| Stockholders' Deficit |
NOTE 4 – STOCKHOLDERS’ DEFICIT
The Company issued 500,000 restricted common shares to founder’s, valued at $500 (based on the par value on the date of grant). The issuance was an isolated transaction not involving a public offering pursuant to Section 4(2) of the Securities Act of 1933.
The Company has authorized 1,000,000 shares of par value $0.001 common stock, of which 500,000 shares are outstanding as of December 31, 2019. |
NOTE 6 – STOCKHOLDERS’ DEFICIT
The Company issued 500,000 restricted common shares to founder’s, valued at $500 (based on the par value on the date of grant). The issuance was an isolated transaction not involving a public offering pursuant to Section 4(2) of the Securities Act of 1933.
The Company has authorized 1,000,000 shares of par value $0.001 common stock, of which 500,000 shares are outstanding at December 31, 2019. |